JUST IN: CDC vaccine advisers have voted 15-0 to change recommendations for Covid-19 vaccines to make clear that shots made by Moderna and Pfizer/BioNTech are preferred over Johnson & Johnson's vaccine.
The new recommendation:"mRNA vaccines are preferred over the Janssen Covid-19 vaccine for the prevention of Covid-19 for those 18 years of age and over."The CDC's Advisory Committee on Immunization Practices endorsed the updated recommendation after hearing new data indicating that a rare blood clotting syndrome is more common among people who recently got a J&J vaccine than previously believed.
ACIP members considered the new data and weighed it against numerous studies showing J&J's vaccine is less effective than the Moderna and Pfizer/BioNTech vaccines in preventing infection. They also discussed the risks of completely removing J&J's vaccine as an option, as well as the potential confusion and mistrust that might be caused by changing recommendations about the vaccine.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
CDC panel recommends Pfizer, Moderna vaccines over J&J shots for adults due to rare blood clot cases
Weiterlesen »
CDC panel recommends Pfizer, Moderna vaccines over J&J shots for adults due to rare blood clot cases
Weiterlesen »
CDC vaccine advisers to revisit Johnson & Johnson Covid-19 vaccine recommendationThe CDC's vaccine advisers will meet on Thursday to revisit the benefits and risks for the Johnson & Johnson Covid-19 vaccine.
Weiterlesen »
CDC advisers to weigh limits on Johnson & Johnson vaccine because of continued blood clot issuesNew data appears to show the incidence has increased since April, although the problem is still rare. About nine deaths related to the issue have also been confirmed.
Weiterlesen »